Literature DB >> 30429194

Antidepressant and antipsychotic prescribing in primary care for people with dementia.

Neil Drummond1, Lynn McCleary2, Elizabeth Freiheit3, Frank Molnar4, William Dalziel5, Carole Cohen6, Diana Turner7, Rebecca Miyagishima8, James Silvius9.   

Abstract

OBJECTIVE: To use data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) to evaluate the prevalence of antidepressant and antipsychotic prescriptions among patients with no previous depression or psychosis diagnoses, and to identify the factors associated with the use of these drugs in this population.
DESIGN: Retrospective cohort study using data derived from CPCSSN.
SETTING: Primary care practices associated with CPCSSN. PARTICIPANTS: Patients who were born before 1949; who were associated with a CPCSSN primary care practitioner between October 1, 2007, and September 30, 2013; and whose electronic medical records contained data from at least 6 months before and 12 months after the date of dementia diagnosis. MAIN OUTCOME MEASURES: Prescription for an antidepressant or antipsychotic medication in the absence of a depression or psychosis diagnosis. Multivariable models were fitted to determine estimated odds ratios (ORs) and were adjusted for age and sex.
RESULTS: Of the 3252 patients without a depression diagnosis, 8.5% received a new prescription for an antidepressant in the 12 months following their diagnosis of dementia. Prescribing was reduced in association with older age (OR of 0.86 per 5-year age increase, P=.001) and male sex (OR=0.77, P=.056), and prescribing increased in association with prescription of cholinesterase inhibitor medications (OR=1.57, P=.003). Of the 4262 patients without a diagnosis of psychosis, 6.1% received a new prescription for an antipsychotic in the 12 months following their diagnosis of dementia. Higher rates of antipsychotic prescriptions were reported in men (OR=1.31, P=.046), those receiving a prescription for steroids (OR=1.90, P=.037), and those diagnosed with Parkinson disease (OR 1.58, P=.051).
CONCLUSION: A substantial number of patients with dementia are being prescribed antidepressant or antipsychotic medications by their primary care practitioners without evidence of depression or psychosis in their electronic medical records. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30429194      PMCID: PMC6234938     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  32 in total

1.  Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial.

Authors:  Sverre Bergh; Geir Selbæk; Knut Engedal
Journal:  BMJ       Date:  2012-03-09

Review 2.  Audit and feedback: effects on professional practice and healthcare outcomes.

Authors:  Noah Ivers; Gro Jamtvedt; Signe Flottorp; Jane M Young; Jan Odgaard-Jensen; Simon D French; Mary Ann O'Brien; Marit Johansen; Jeremy Grimshaw; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

3.  Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations--a questionnaire study.

Authors:  J Cockburn; S Pit
Journal:  BMJ       Date:  1997-08-30

4.  Prevalence and management of dementia in primary care practices with electronic medical records: a report from the Canadian Primary Care Sentinel Surveillance Network.

Authors:  Neil Drummond; Richard Birtwhistle; Tyler Williamson; Shahriar Khan; Stephanie Garies; Frank Molnar
Journal:  CMAJ Open       Date:  2016-04-28

5.  Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Authors:  Daniel Weintraub; Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine Frangakis; Jacobo E Mintzer; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

6.  The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey.

Authors:  N Britten; O Ukoumunne
Journal:  BMJ       Date:  1997-12-06

7.  Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.

Authors:  S Banerjee; J Hellier; R Romeo; M Dewey; M Knapp; C Ballard; R Baldwin; P Bentham; C Fox; C Holmes; C Katona; C Lawton; J Lindesay; G Livingston; N McCrae; E Moniz-Cook; J Murray; S Nurock; M Orrell; J O'Brien; M Poppe; A Thomas; R Walwyn; K Wilson; A Burns
Journal:  Health Technol Assess       Date:  2013-02       Impact factor: 4.014

Review 8.  Depression and dementia: comorbidities, identification, and treatment.

Authors:  B S Meyers
Journal:  J Geriatr Psychiatry Neurol       Date:  1998       Impact factor: 2.680

9.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

10.  Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Authors:  Constantine G Lyketsos; Lourdes DelCampo; Martin Steinberg; Quincy Miles; Cynthia D Steele; Cynthia Munro; Alva S Baker; Jeannie-Marie E Sheppard; Constantine Frangakis; Jason Brandt; Peter V Rabins
Journal:  Arch Gen Psychiatry       Date:  2003-07
View more
  5 in total

1.  Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden.

Authors:  Sofia Svahn; Hugo Lövheim; Ulf Isaksson; Per-Olof Sandman; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2020-01-08       Impact factor: 2.953

2.  Pelvic floor disorders in women who consult primary care clinics: development and validation of case definitions using primary care electronic medical records.

Authors:  Sue Ross; Hilary Fast; Stephanie Garies; Deb Slade; Dave Jackson; Meghan Doraty; Rebecca Miyagishima; Boglarka Soos; Matt Taylor; Tyler Williamson; Neil Drummond
Journal:  CMAJ Open       Date:  2020-05-28

Review 3.  Parkinson's Disease in Women and Men: What's the Difference?

Authors:  Silvia Cerri; Liudmila Mus; Fabio Blandini
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

4.  Variation and appropriateness of antipsychotic use in long-term care facilities across Newfoundland and Labrador.

Authors:  Zachary E M Giovannini-Green; John-Michael Gamble; Brendan Barrett; Zhiwei Gao; Susan Stuckless; Patrick S Parfrey
Journal:  Can Pharm J (Ott)       Date:  2021-04-23

5.  Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals.

Authors:  Alok Joshi; Stephen Todd; David P Finn; Paula L McClean; KongFatt Wong-Lin
Journal:  BMC Med Inform Decis Mak       Date:  2022-10-07       Impact factor: 3.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.